Molecular Endocrinology, Vol 7, 1169-1177, Copyright © 1993 by Endocrine Society

ARTICLES

Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis- acting regulatory elements

CJ Bruzdzinski, MR Johnson, CA Goble, SS Winograd and TD Gelehrter
Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618.

Type 1 plasminogen activator inhibitor (PAI-1) is the major physiological inhibitor of plasminogen activation, inhibiting both tissue- and urokinase-type plasminogen activators. In HTC rat hepatoma cells, glucocorticoids increase PAI-1 activity, antigen and mRNA accumulation 3- to 5-fold; this increase is due solely to an increase in the rate of PAI-1 gene transcription. We have identified the cis- acting sequences in the 5'-flanking sequence of the HTC PAI-1 gene that mediate this induction. Analysis of a series of hybrid genes containing various portions of the PAI-1 5'-flanking region fused to the chloramphenicol acetyltransferase reporter gene transfected into HTC cells localized the region involved in the transcriptional regulation by glucocorticoids to between -1237 and -764. Electrophoretic mobility shift assays and DNase-I protection assays showed that a glucocorticoid response element (GRE) 15-mer located at -1212 bound the glucocorticoid receptor DNA-binding domain protein in a concentration-dependent manner. Mutations created within this GRE eliminated its ability both to confer a glucocorticoid response and to bind the glucocorticoid receptor. When placed upstream of a heterologous promoter in either orientation, this GRE conferred glucocorticoid inducibility. We, therefore, conclude that the sole cis-acting sequence required for the glucocorticoid response of the PAI-1 gene in rat HTC hepatoma cells is the GRE at -1212.

This article has been cited by other articles:

				G. Fejes-Toth and A. Naray-Fejes-Toth Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling? Endocrinology, April 1, 2007; 148(4): 1502 - 1510. [Abstract] [Full Text] [PDF]

				M. E. Young The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H1 - H16. [Abstract] [Full Text] [PDF]

				A. I. Vulin and F. M. Stanley A Forkhead/Winged Helix-related Transcription Factor Mediates Insulin-increased Plasminogen Activator Inhibitor-1 Gene Transcription J. Biol. Chem., May 31, 2002; 277(23): 20169 - 20176. [Abstract] [Full Text] [PDF]

				S. Chandrasekhar, W. W. Souba, and S. F. Abcouwer Identification of glucocorticoid-responsive elements that control transcription of rat glutamine synthetase Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L319 - L331. [Abstract] [Full Text] [PDF]

				T. M. Coffman, R. F. Spurney, R. B. Mannon, and R. Levenson Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells Am J Physiol Renal Physiol, August 1, 1998; 275(2): F262 - F269. [Abstract] [Full Text] [PDF]

				R. N. Woodward, M. Li, and L. J. Holland Novel Accessory Factor-Binding Site Required for Glucocorticoid Regulation of the {gamma}-Fibrinogen Subunit Gene from Xenopus laevis Mol. Endocrinol., May 1, 1997; 11(5): 563 - 576. [Abstract] [Full Text]